TERT and neoplasm: In the experimental cohort of Ekedahl et al., the mutation rate of TERT promoter in the tumor tissue of patients with nonacral cutaneous metastatic melanoma was high, which may represent a greater metastatic potential in the primary tumor of TERT promoter mutations [40].